Literature DB >> 17275090

Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.

Jennifer S L Tan1, Paul Mitchell, Wayne Smith, Jie Jin Wang.   

Abstract

PURPOSE: To assess the relationship between cardiovascular disease and cardiovascular risk factors, other than smoking, and risk of long-term incident age-related macular degeneration (AMD).
DESIGN: Population-based cohort study. PARTICIPANTS: There were 3654 baseline (1992-1994) participants aged > or = 49 years included in the Blue Mountains region, west of Sydney, Australia. Of these, 2335 (75% of survivors) were reexamined after 5 years (1997-1999) and 1952 (76% of survivors) after 10 years (2002-2004).
METHODS: Stereoscopic color fundus photographs were graded using the Wisconsin Age-related Maculopathy Grading System. History, physical examination, and fasting blood samples provided data on possible risk factors. Age-related macular degeneration incidence was calculated using the Kaplan-Meier survival approach. Discrete linear logistic models were used to assess risk of incident AMD. Relative risks (RR) and 95% confidence intervals (CI) are presented after adjusting for age, gender, smoking, and other risk factors. MAIN OUTCOME MEASURE: Incident early and late AMD.
RESULTS: Increasing high-density lipoprotein (HDL) cholesterol was inversely related to incident late AMD (RR per standard deviation [SD] increase, 0.74; 95% CI, 0.56-0.99). Elevated total/HDL cholesterol ratio predicted late AMD (RR per SD increase, 1.35; 95% CI, 1.07-1.70) and geographic atrophy (GA; RR per SD, 1.63; 95% CI, 1.18-2.25). Diabetes predicted incident GA (RR, 3.89; 95% CI, 1.36-11.08), but not neovascular AMD. History of stroke (RR 2.01; 95% CI, 1.12-3.58), or any cardiovascular disease (stroke, myocardial infarction, or angina; RR, 1.57; 95% CI, 1.13-2.16) predicted incident early AMD and incident indistinct soft or reticular drusen (RR, 2.38; 95% CI, 1.33-4.27 for stroke; RR, 1.80; 95% CI, 1.28-2.52 for any cardiovascular disease). Neither pulse pressure, systolic or diastolic blood pressure, or presence of hypertension at baseline were associated with incident AMD.
CONCLUSIONS: Our findings provide some evidence of links between cardiovascular risk factors and AMD. Further prospective evaluation of these relationships is warranted, as these findings could have therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17275090     DOI: 10.1016/j.ophtha.2006.09.033

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  77 in total

Review 1.  Role of Lipids in Retinal Vascular and Macular Disorders.

Authors:  Gunjan Prakash; Rachit Agrawal; Tanie Natung
Journal:  Indian J Clin Biochem       Date:  2016-03-08

2.  [Age-related macular degeneration and risk of stroke].

Authors:  V Biousse; M-G Bousser; A Gaudric
Journal:  J Fr Ophtalmol       Date:  2008-01       Impact factor: 0.818

3.  One-year results of intravitreal ranibizumab for neovascular age-related macular degeneration and clinical responses of various subgroups.

Authors:  Seungbum Kang; Young-Jung Roh
Journal:  Jpn J Ophthalmol       Date:  2009-09-08       Impact factor: 2.447

4.  Effect of 1-year lutein supplementation on macular pigment optical density and visual function.

Authors:  Yuzuru Sasamoto; Fumi Gomi; Miki Sawa; Motokazu Tsujikawa; Kohji Nishida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-18       Impact factor: 3.117

5.  The prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom.

Authors:  L-Y Ngai; N Stocks; J M Sparrow; R Patel; A Rumley; G Lowe; G Davey Smith; Y Ben-Shlomo
Journal:  Eye (Lond)       Date:  2011-03-25       Impact factor: 3.775

6.  Genetic determinants of age-related macular degeneration in diverse populations from the PAGE study.

Authors:  Nicole A Restrepo; Kylee L Spencer; Robert Goodloe; Tiana A Garrett; Gerardo Heiss; Petra Bůžková; Neal Jorgensen; Richard A Jensen; Tara C Matise; Lucia A Hindorff; Barbara E K Klein; Ronald Klein; Tien Y Wong; Ching-Yu Cheng; Belinda K Cornes; E-Shyong Tai; Marylyn D Ritchie; Jonathan L Haines; Dana C Crawford
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-09       Impact factor: 4.799

7.  Prevalence of intermediate-stage age-related macular degeneration in patients with acquired immunodeficiency syndrome.

Authors:  Douglas A Jabs; Mark L Van Natta; Efe Sezgin; Jeong Won Pak; Ronald Danis
Journal:  Am J Ophthalmol       Date:  2015-03-11       Impact factor: 5.258

8.  Prospective study of incident age-related macular degeneration in relation to vigorous physical activity during a 7-year follow-up.

Authors:  Paul T Williams
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-19       Impact factor: 4.799

9.  Association between dietary fat intake and age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS): an ancillary study of the Women's Health Initiative.

Authors:  Niyati Parekh; Rickie P Voland; Suzen M Moeller; Barbara A Blodi; Cheryl Ritenbaugh; Richard J Chappell; Robert B Wallace; Julie A Mares
Journal:  Arch Ophthalmol       Date:  2009-11

10.  Ocular fundus abnormalities in patients with Balkan endemic nephropathy and other chronic kidney diseases.

Authors:  Jasmina Djordjevic Jocic; Rade Cukuranovic; Predrag Jovanovic; Vidosava Djordjevic; Marija Mihajlovic; Dragan Bogdanovic; Jovana Cukuranovic-Kokoris; Vladisav Stefanovic
Journal:  Int Urol Nephrol       Date:  2015-09-02       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.